The deadline passes, the call ends, the day should be over — yet something in you keeps running. The body stays slightly charged, the mind keeps scanning, and even when silence returns, a faint current of alertness remains. It feels like responsibility, but it’s chemistry.
The same system that kept you composed under pressure hasn’t stood down. Cortisol — the hormone that keeps attention sharp and reaction time fast — continues to circulate, protecting you from threats that no longer exist. What feels like vigilance is often the cortisol feedback loop in its final act — Alertness After Completion — when the body stays ready even though the work is finished.
This loop explains why recovery can feel unnatural. The external task has ended, but internally the system remains active, waiting for confirmation that it’s safe to rest. Until that signal arrives, the body stays on alert — not from stress, but from continuation.
How the Loop Works
Like every cortisol loop, it unfolds in three predictable stages: trigger → response → reinforcement.
It begins with a trigger — completion without closure. The project is done, the pressure released, yet the nervous system doesn’t register resolution. The sudden stillness feels incomplete, as if something has been left unchecked.
The response follows automatically. Cortisol remains elevated, keeping the body in a low-grade state of readiness. You feel tired but alert, replaying conversations, scanning emails, or rehearsing answers for questions that may never come. It feels like control, but it’s chemistry searching for unfinished business.
Then comes reinforcement. Each mental check or late-night thought provides a brief sense of relief — and that relief teaches the system that vigilance is useful. Over time, the body learns that calm equals risk and movement equals safety. Even rest becomes a form of work.
This isn’t overthinking; it’s biology running past its stop signal.
Related article: Read how this loop fits within the broader Neurochemical Decision Cycle — the three-stage model that explains how chemistry shapes decision-making, daily execution, recovery, and rest.
The Carryover Effect
For executives, this continuation often hides behind professionalism. You’re across every detail, available, engaged. The calendar says “finished,” but the chemistry doesn’t. The body remains slightly charged, the mind slightly vigilant, as though recovery needs permission.
This carryover creates subtle distortion. When cortisol stays active, you wake already braced for the day ahead. Focus narrows, patience shortens, and energy depletes faster — not from exertion, but from unfinished shutdown. The system keeps yesterday’s readiness as today’s baseline, and performance gradually shifts from clarity to tension.
The 3 A.M. Alert
James, CEO of a technology company, was known for his steadiness — composed in pressure, decisive in uncertainty. Yet his discipline carried a hidden cost. Long after the day ended, his system stayed on. At 3 a.m., his eyes would open suddenly — pulse elevated, thoughts already in motion. There was no noise, no crisis, no message. Just the familiar sense that something needed attention.
The alert didn’t begin with thought; it began with chemistry. During the day, dopamine had rewarded momentum — each solved issue, each decision made, each moment of control. By night, that drive for completion left a chemical trace, and cortisol took over to keep the system ready. The two loops — reward and vigilance — now worked in sequence: dopamine built the pursuit, cortisol refused to release it.
Each time James scanned for what might be wrong — Did I miss something? What’s waiting tomorrow? — the search reactivated both systems. Dopamine promised resolution; cortisol sustained alertness. Together they created motion without movement — a mind convinced that thinking was progress.
What looked like discipline by day became vigilance by night. His nervous system had learned that readiness meant safety, and quiet meant risk. The turning point came not through exhaustion, but through recognition. By naming the state — this is chemistry, not crisis — he gave his system the signal it needed. Over time, the wakefulness faded, not through control, but through release.
The Cost of Unfinished Shutdown
Cortisol is not the enemy. It’s what keeps you alert in danger, sharp in negotiation, and calm under pressure. But when it fails to deactivate, it turns vigilance into depletion.
The real cost isn’t just fatigue — it’s distortion. A system that never resets carries the chemistry of the last challenge into the next one. Decisions made under residual cortisol tend to be defensive, risk-averse, or excessively controlling. You start managing the feeling of potential loss rather than the logic of actual opportunity.
Over time, this incomplete shutdown narrows your range. You still perform, but from tension rather than composure. You recover only when exhaustion forces it.
This is why recovery is not optional — it’s operational. It’s not the opposite of productivity; it’s the process that returns clarity to it.
Restoring Balance
The goal isn’t to eliminate vigilance; it’s to stop carrying it forward. Cortisol’s job is to protect you — but without deliberate closure, it will protect you from rest itself.
When you can sense the moment the loop reactivates — the 3 a.m. alertness, the thought spiral that starts with “just checking” — you can intervene before it runs. That recognition is the turning point: awareness replaces reaction, and the system begins to reset on demand.
Recovery, then, becomes strategic. It’s the skill that prevents today’s performance from becoming tomorrow’s fatigue.
If you’d like to see how this loop shows up in your own recovery rhythm — how often alertness continues after pressure ends — you can take the Decision Excellence Assessment. It maps how dopamine and cortisol shape your logic, energy, and recovery cycles, revealing where chemistry may still be running when it should be resting.
Tomasz Drybala – Author, Researcher, Coach, and Director of the Neuro-Based Leadership Centre
My work is grounded in lived experience, research, and ongoing studies with more than 100 CEOs and senior executives — examining how dopamine–cortisol dynamics influence decision-making, execution, and recovery under pressure.
My academic development now includes targeted programs at Harvard, Cambridge, Oxford, and the University of California, Berkeley. I am pursuing a Master’s and — fingers crossed — a PhD in Applied Neuroscience, specialising in decision-making.
I’m also the author of three forthcoming books exploring the neurochemistry of leadership, including Breaking Patterns (September 2026), Neuroscience of CEO Decision-Making (January 2027), and Choosing the Right People (March 2027).